![Thomas R. Northenscold](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas R. Northenscold
Geen lopende functies
Loopbaan van Thomas R. Northenscold
Eerdere bekende functies van Thomas R. Northenscold
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Daig Corp.
![]() Daig Corp. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Daig Corp. is a company that manufactures specialty catheters. The company is based in Hopkins, MN. Daig was acquired by St. Jude Medical LLC, part of Abbott Laboratories from January 05, 2017 on May 31, 1996 for $439.60 million. | Hoofd Administratief Officier | 01-01-2001 | - |
Financieel Directeur/CFO | 01-01-2001 | - | |
ST JUDE MEDICAL INC | Hoofd Techniek/Wetenschap/O&O | 01-03-2003 | - |
Opleiding van Thomas R. Northenscold
Minnesota State University-Mankato | Undergraduate Degree |
University of Michigan | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 5 |
Operationeel
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
St. Jude Medical LLC
![]() St. Jude Medical LLC Medical SpecialtiesHealth Technology St. Jude Medical LLC develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The company was founded by Manuel A. Villafana in 1976 and is headquartered in St. Paul, MN. | Health Technology |
Daig Corp.
![]() Daig Corp. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Daig Corp. is a company that manufactures specialty catheters. The company is based in Hopkins, MN. Daig was acquired by St. Jude Medical LLC, part of Abbott Laboratories from January 05, 2017 on May 31, 1996 for $439.60 million. | Health Technology |